期刊文献+

铂类抗癌药物作用机理研究进展 被引量:1

Recent Progress in the Anti-Tumor Mechanics of Platinum-Based Drugs
下载PDF
导出
摘要 顺铂、卡铂的开发成功和临床应用给癌症治疗带来了一场新的革命,几种新型铂类抗癌药物的成功推出开辟了铂类抗癌药物研究新领域。 The successful development and clinical application of anti-tumor drugs such as Cisplatinum and Carbonplatinum has brought a new revolution in the therapy of tumors. Some novel non-classical trans-platinum drugs have been come into use and have triggered the research into the usage of platinum anticancer drugs. In this article, the progress in the theoretical and experimental study of the anticancer mechanism of the platinum based drugs in recent years is reviewed.
机构地区 黄山学院化学系
出处 《黄山学院学报》 2007年第5期45-47,共3页 Journal of Huangshan University
基金 黄山学院自然科学基金项目(2006xkjq007)
关键词 双功能加合物 铂类抗癌药物 抗癌机理 mono-difunetional adduet platinum antieaneer drugs antieaneer mechanism.
  • 相关文献

参考文献2

二级参考文献27

  • 1[1]Elizabeth R J, Stephen J L. Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev, 1999, 99(8): 2467~2498 被引量:1
  • 2[2]Perez R P. Cellular and molecular determinations of cisplatin resistance. European Journal of Cancer, 1998, 34(10): 1535~1542 被引量:1
  • 3[3]Raynaud F I, Boxall F E, Goddard P M, et al. Cis-amminedichloro(2-methylpyridine) platinum(Ⅱ) (AMD473), a novel sterically hindered platinum complex: In vivo activity toxicology and pharamacokinetics in mice. Clinical Cancer Research, 1997, 3: 2063~2074 被引量:1
  • 4[4]Holford J, Sharp S Y, Murrer B A, et al. In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473. British Journal of Cancer, 1998, 77(3): 366~373 被引量:1
  • 5[5]Chen Y, Guo Z, Parkinson J A, et al. Kinetic control of a sterically hindered platinum picoline anticancer complex with guanosine 5′-monophosphate and glutathione. J Chem Soc Dalton Trans, 1998, 3577~3585 被引量:1
  • 6[6]Wang E, Giandomenico C M. Current status of platinum-based antitumer drugs. Chemical Reviews, 1999, 99(8): 2451~2466 被引量:1
  • 7[7]Bradley L J N, Yarema K J, Lippard S J, et al. Mutagenicity and genotoxicity of the major DNA adduct of the antitumer drug cis-diamminedichloroplatinum(Ⅱ). Biochemistry, 1993, 32: 982~988 被引量:1
  • 8[8]Chow C S, Barnes C M, Lippard S J. A single HMG domain in high-mobility groupⅠ protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct. Biochemistry, 1995, 33: 2954~2964 被引量:1
  • 9[9]Ohndorf U M, Whitehead J P, Raju N L. et al. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts. Biochemistry, 1997, 36: 14807~14815 被引量:1
  • 10[10]Trimmer E E, Zamble D B, Lippard S J, et al. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities. Biochemistry, 1998, 37: 352~362 被引量:1

共引文献12

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部